Researchers Discover Genetic Marker to Identify Aggressive Prostate Cancers Early
A genetic variant in the PSA gene may help improve prostate cancer diagnostics by distinguishing between aggressive and non-aggressive types.
Read MorePosted by Andy Lundin | Nov 12, 2024 | Molecular Diagnostics, Prostate |
A genetic variant in the PSA gene may help improve prostate cancer diagnostics by distinguishing between aggressive and non-aggressive types.
Read MorePosted by Andy Lundin | Nov 4, 2024 | Sexually Transmitted Diseases |
WHO has granted Cepheid’s Xpert Mpox test Emergency Use Listing, enabling rapid, point-of-care mpox detection to support outbreak management.
Read MorePosted by Chris Wolski | Oct 31, 2024 | Emerging & Zoonotic Diseases |
A new noninvasive malaria test can detect malaria-infected cells in the bloodstream without requiring a blood sample.
Read MorePosted by Chris Wolski | Oct 30, 2024 | Immunoassay |
New England Biolabs is improving accessibility with a range of development tools, including shelf-stable reagents and enzyme-based tools.
Read MorePosted by Andy Lundin | Oct 24, 2024 | Cancer |
Researchers have created a portable device that can detect colorectal and prostate cancer more cheaply and quickly than prevailing methods.
Read More